Chinese company starts mass producing Gilead coronavirus drug
February 12, 2020Research and Development Ebola, Wuhan, Wuhan Coronavirus, china coronavirus
A drugmaker in China said it has started mass producing Gilead Sciences Ebola drug that has the potential to fight …
Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune
February 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AC Immune, Interview, Working Life, feature, pharma
What originally set you off on your career path? Was the plan always to go into the pharma and biotech …
Eli Lilly’s solanezumab fails at Phase 2/3 in early-onset Alzheimer’s disease
February 11, 2020Manufacturing and Production Alzheimer's Eli Lilly, pharma, trial failure
In another blow to Alzheimer’s research, it has emerged that a study investigating Eli Lilly’s solanezumab in the treatment of …
Scotland approves targetted combination therapy for advanced melanoma
February 11, 2020Manufacturing and Production NHS, SMC, Scotland, UK, advanced melanoma, melanoma
The Scottish Medicines Consortium (SMC) has approved targeted combination therapy for the treatment of adult patient with unresectable or metastatic …
Type 2 diabetes cases up 40% in Scotland
February 11, 2020Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes
According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …
Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma
February 11, 2020Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma
Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …
Patient successfully treated for coronavirus in the US
February 11, 2020Manufacturing and Production Chinese Coronavirus, Coronavirus Wuhan, Ebola, Wuhan Coronavirus, coronavirus
Health officials in the US say they have successfully treated a man for coronavirus with an experimental drug. The Ebola …
Roche’s experimental Alzheimer’s drug does not meet primary endpoint in clinical trials
February 10, 2020Sales and Marketing Alzheimer's, Roche, roche Alzheimer
Roche has said its experimental drug, gantenerumab, did not meet its primary endpoint in people who have an inherited form …
Nanoform establishes US subsidiary
February 10, 2020Sales and Marketing nano, nano science, nanotech
Nanoform has set up an American subsidiary, ‘Nanoform USA’, due to increasing demand for the companies CESS technology.Its patented CESS …
FDA approves Caption Health’s AI-guided imaging system
February 10, 2020Sales and Marketing AI, Caption Health, FDA, ultrasound, ultrasound imaging
The FDA have given marketing approval for Caption Health’s Caption Guidance and its use in cardiac ultrasound images.The technology allows …
Several European cases of coronavirus traced to ski resort in the Alps
February 10, 2020Sales and Marketing china coronavirus, coronavirus, vietnam coronavrisu, wuhan cornavirus
Multiple European cases of coronavirus have been traced to a ski resort in the Alps, with a British man spread …
Vietnam develops quick coronavirus test kit
February 10, 2020Sales and Marketing Wuhan Coronavirus, china coronavirus, coronavirus, vietnam, vietnam coronavirus
Researchers in Vietnam have developed a coronavirus test kit which provides results in 70 minutes instead of four hours like …
Galecto hires new Chief Medical Officer
February 7, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto
Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …
New Chief Medical Officer joins Khondrion
February 7, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO). Dr …
Top Ten most popular articles on Pharmafile.com this week
February 7, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs
The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …
85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds
February 7, 2020Medical Communications, Research and Development clinical trials, pharma
Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …
Third person in the UK diagnosed with coronavirus
February 7, 2020Medical Communications China, Coronavirus Wuhan, MERS, Sars, coronavirus, coronavirus China
A third British person has been diagnosed with the coronavirus, which he allegedly caught in Singapore.He was tested in Brighton …
GSK to axe 720 positions at Belgian vaccine facility
February 7, 2020Manufacturing and Production, Medical Communications GSK, job cuts, pharma
GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …
Jury orders Johnson & Johnson to pay $750 million in latest baby powder case
February 7, 2020Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder
Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …
AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3
February 6, 2020Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis
AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
